The COR-I trial, involving 1,742 participants over 56 weeks, demonstrated 6.1% average weight loss with Contrave versus 1.3% with placebo (Greenway et al., Obesity, 2010)
A 2023 study published in The Journal of Clinical Endocrinology & Metabolism found that men with obesity taking tirzepatide experienced significant increases in total testosterone levels as they lost weight
While its potential as a systemic anti-aging therapeutic is heavily discussed in longevity circles, the optimal delivery method to target the central nervous system has remained speculative
Low copays for most services after deductible is met 40 alternative care visits per year for chiropractic care and acupuncture combined No additional cost for telehealth through Teladoc Health * No additional cost for Lab Savings Program* The MHBP Consumer Option comes with a tax-advantaged HSA We contribute up to $2,400 per year for Self Plus One or Self and Family coverage ($1,200 for Self Only) to use for qualified medical expenses
The public repository of xenografts enables discovery and randomized Phase II-like trials in mice
This raises concerns about l carnitine and heart health, as increased TMAO levels can pose risks